Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enovis Corp (ENOV)

Enovis Corp (ENOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,299,906
  • Shares Outstanding, K 57,189
  • Annual Sales, $ 2,108 M
  • Annual Income, $ -825,490 K
  • EBIT $ 76 M
  • EBITDA $ 1,011 M
  • 60-Month Beta 1.52
  • Price/Sales 0.58
  • Price/Cash Flow 1.16
  • Price/Book 0.63

Options Overview Details

View History
  • Implied Volatility 76.23% (+3.92%)
  • Historical Volatility 54.89%
  • IV Percentile 88%
  • IV Rank 51.66%
  • IV High 109.75% on 02/02/26
  • IV Low 40.40% on 03/26/25
  • Expected Move (DTE 26) 1.70 (7.48%)
  • Put/Call Vol Ratio 3.00
  • Today's Volume 24
  • Volume Avg (30-Day) 139
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 8,549
  • Open Int (30-Day) 7,154
  • Expected Range 21.03 to 24.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.81
  • Number of Estimates 2
  • High Estimate 0.81
  • Low Estimate 0.81
  • Prior Year 0.98
  • Growth Rate Est. (year over year) -17.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.00 +8.24%
on 01/29/26
24.46 -7.07%
on 01/22/26
-0.36 (-1.56%)
since 01/20/26
3-Month
21.00 +8.24%
on 01/29/26
30.93 -26.51%
on 12/01/25
-4.10 (-15.28%)
since 11/20/25
52-Week
21.00 +8.24%
on 01/29/26
44.03 -48.38%
on 02/21/25
-21.17 (-48.22%)
since 02/20/25

Most Recent Stories

More News
1 Volatile Stock with Promising Prospects and 2 We Ignore

1 Volatile Stock with Promising Prospects and 2 We Ignore

ENOV : 22.73 (+1.93%)
COHR : 248.18 (+6.75%)
MCHP : 77.73 (+0.74%)
3 Volatile Stocks We’re Skeptical Of

3 Volatile Stocks We’re Skeptical Of

ENOV : 22.73 (+1.93%)
SEE : 41.95 (+0.07%)
OC : 132.71 (+0.78%)
Enovis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Dallas TX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that management will participate in the BTIG...

ENOV : 22.73 (+1.93%)
3 Value Stocks We Keep Off Our Radar

3 Value Stocks We Keep Off Our Radar

ENOV : 22.73 (+1.93%)
NCLH : 24.31 (+2.40%)
BK : 118.19 (+0.03%)
Enovis to Host Fourth Quarter and Full Year 2025 Results Conference Call on February 26th

Dallas, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and...

ENOV : 22.73 (+1.93%)
3 Out-of-Favor Stocks We Keep Off Our Radar

3 Out-of-Favor Stocks We Keep Off Our Radar

ENOV : 22.73 (+1.93%)
CMRC : 3.02 (+2.72%)
DOMO : 3.90 (+5.69%)
Enovis to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dallas, TX, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with investors...

ENOV : 22.73 (+1.93%)
Enovis Appoints Oliver Engert as Chief Administrative Officer

Dallas, TX, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology company, has announced that Oliver Engert has been appointed Chief Administrative...

ENOV : 22.73 (+1.93%)
3 Unprofitable Stocks That Concern Us

3 Unprofitable Stocks That Concern Us

ENOV : 22.73 (+1.93%)
PACB : 1.6100 (-4.17%)
BGS : 5.28 (+2.52%)
Why Enovis (ENOV) Stock Is Trading Up Today

Why Enovis (ENOV) Stock Is Trading Up Today

ENOV : 22.73 (+1.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

See More

Key Turning Points

3rd Resistance Point 24.05
2nd Resistance Point 23.50
1st Resistance Point 23.11
Last Price 22.73
1st Support Level 22.17
2nd Support Level 21.62
3rd Support Level 21.23

See More

52-Week High 44.03
Fibonacci 61.8% 35.23
Fibonacci 50% 32.51
Fibonacci 38.2% 29.80
Last Price 22.73
52-Week Low 21.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar